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Abstract
Introduction Renal function after renal surgery
depends on the volume of renal parenchyma loss and
improves in the postoperative period. However, the
knowledge on kidney function after radical (RN) and
partial (PN) nephrectomy is still insufﬁcient. The aim
of this study is to analyze the global renal function
and compensatory hyperfunction of the non-operated
kidney in patients with renal cancer after RN or PN.
Methods Fifty-one patients of mean age 62.2 years
with renal cancer were included. Thirty-three RN and
eighteen PN were performed. We measured creatinine
serum concentrations, and we estimated glomerular
ﬁltration rate (eGFR) preoperatively and postopera-
tively at two time intervals: 3 and 12 months after
surgery. Additionally, we assessed effective renal
plasma ﬂow (ERPF) in dynamic scintigraphy preop-
eratively and 12 months after surgery.
Result At the baseline, all mean measured values
were comparable in RN and PN groups (P[0.05).
Three months after surgery, creatinine level increased
in both groups, more remarkably in RN group
(128 mmol/l vs. 95 mmol/l; P\0.05), while eGFR
diminished(47 ml/min/1.73 m
2vs.70 ml/min/1.73 m
2;
P\0.05). Similar biochemical values were observed
12 months after surgery. The mean ERPF of the non-
operated kidney 12 months after surgery in RN and PN
groups increased by 3.8% (232 ml/min) and 0.1%
(200 ml/min), respectively (P[0.05). The mean ERPF
of the operated kidney in PN group decreased by 24.7%
(149 ml/min).
Conclusion The deterioration of renal function after
partial nephrectomy is nearly insigniﬁcant clinically.
In 1-year postoperative observation, the renal function
does not improve. This causes potential compensatory
mechanisms to be insufﬁcient.
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Introduction
The ﬁrst planned successful nephrectomy was
performed in 1869 by Gustav Simon [1]. Over time,
we have expanded our knowledge and reﬁned surgical
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cols. However, the knowledge of renal function and
compensatory mechanisms following nephrectomy in
renal cancer patients has not progressed much further
than what Simon had learned from the experiments
performed in the seventeenth century by Hendrik
von Roonhuysen, Giuseppe Zambeccarius, Stephan
Blankaard,andothers.Theseresearchersprovedthatit
was possible to live with a single kidney and
demonstrated limited compensative hypertrophy in
the residual kidney [2].
Renal cancer is one of the most frequently occur-
ring neoplasms. Its incidence is still on the rise,
contributing to renal surgery becoming increasingly
more common [3]. One of the most interesting and
important observations derived from the clinical data
of patients qualiﬁed for nephrectomy or nephrectom-
ized is the inﬂuence exerted by renal parenchyma
reduction on global renal function. Our current
working hypothesis is that patients undergoing renal
surgery suffer from deterioration of renal function
dependingon the volumeof renal parenchymaloss but
that the global renal function during long-term follow-
up improves as a consequence of the compensatory
mechanism produced by contralateral kidney hyper-
function [4]. The extent of our knowledge on kidney
function after radical (RN) and partial (PN) nephrec-
tomy as a consequence of renal cancer, however, is
insufﬁcient and must be expanded.
Aim
The aim of the study is to analyze the impact exerted
by renal surgery on global renal function and the
compensatory hyperfunction of the non-operated
kidney in radical and partial nephrectomy surgery.
Materials and methods
Population
62 white race patients with renal cancer were enrolled
in the study prospectively. All the patients gave
writtenconsent toparticipateinthestudy.Meantumor
size was 5.3 9 4.4 9 4.5 cm. One-year follow-up
was performed completely in 51 patients (28 men and
23 women). RN was performed in 33 patients (2 T1a,
17 T1b, 10 T2, and 4 T3 tumors) and PN in 18 patients
(18 T1a tumors). The mean age in the cohort was
62.2 years (42–78). Table 1 summarizes basic demo-
graphic and clinical data of the cohort. Hypertension
was deﬁned as systolic pressure over 140 mmHg and
diastolic pressure over 90 mmHg at two visits or
hypotensive therapy, hypercholesterolemia as total
cholesterol serum concentration [5.17 mmol/l or
hypolipemic therapy, hyperuricemia as uric acid
serum concentration[428 mmol/l, diabetes as hypo-
glycemic therapy.
Intervention
The inﬂuence of surgery on renal function was
compared generally between RN group and PN group,
as well as regarding to age (patients younger and
older than 60 years) and arterial hypertension (hyper-
and normotensive patients). The kidney function was
assessed preoperatively and postoperatively in two
time intervals: at 3 and 12 months after surgery
by measuring serum creatinine concentration, and
subsequently by calculating the estimated glomerular
ﬁltration rate (eGFR) using the Modiﬁcation of
Diet Renal Disease (MDRD) formula. Additionally,
effective renal plasma ﬂow (ERPF) in dynamic
scintigraphy with technetium-99 m ethylenedicysteine
Table 1 Basic
demographic and clinical
data of the cohort
The unpaired t test was used
for age comparison, and the
v
2 test was used for all
qualitative variables
RN group (n = 33) PN group (n = 18) P value
Mean age 61.9 62.7 0.77
Female to male ratio 1:1.4 1:1.3 0.95
Number of pts aged[60 years 20 (61%) 10 (56%) 0.73
Number of hypertensive pts 22 (67%) 12 (67%) 1.00
Number of pts with hypercholestrolemia 11 (33%) 4 (22%) 0.41
Number of pts with hyperuricemia 4 (12%) 4 (22%) 0.34
Number of diabetic pts 6 (18%) 3 (17%) 0.89
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99mTc-EC) as a radiopharmaceutical was measured
preoperatively and postoperatively 12 months after sur-
gery to assess the differences in each kidney separately.
Statistical analysis
The paired t test was used to compare the measured
values at different follow-up points within study
groups. To compare selected parameters in partially
versus radicallynephrectomizedpatients,the unpaired
t test was used for quantitative variables and v
2 test for
qualitative variables. Normal distribution was con-
ﬁrmed by the Shapiro–Wilk test, while the equality of
variances was assessed using Levene’s test before all
the t tests were performed. The differences were
considered to be statistically signiﬁcant when the
P value was \0.02. The measurement results are
expressed as mean values and standard deviations; in
addition, range and/or percentage of change are
presented for selected parameters.
Results
The differences between the RN and PN groups in the
mean values were not statistically signiﬁcant at the
baseline. Statistically signiﬁcant results are summa-
rized in Tables 2 and 3.
Serum creatinine concentration
Patients in both groups had a high baseline serum
creatinine concentration, at the upper limit of the
reference range (44–94 mmol/l). Thus, surgery is very
important for renal function measured by serum
creatinine concentration. Postoperative mean values
were above normal in both groups with the difference
between the baseline and the measured results
3 months after surgery being statistically signiﬁcant
in RN group (P\0.02).
Estimated glomerular ﬁltration rate
According to chronic kidney disease classiﬁcation,
patients in our cohortsuffered stage one of this disease
preoperatively (eGFR under 90 ml/min/1.73 m
2 and
over 60 ml/min/1.73 m
2). However, surgery signiﬁ-
cantly deteriorated renal function, shifting our patients
to more advanced stages of chronic kidney disease.
The drop in the ﬁrst 3 months of observation is
statistically signiﬁcant in RN group (P\0.02), as
opposed to subsequent growth over the following
9 months.
Effective renal plasma ﬂow
The preoperative differences in mean global ERPF
in the RN and PN groups were not statistically
signiﬁcant. During the 1-year postoperative follow-
up, we noticed a decrease in global ERPF in both
groups, by 38% in the RN group and 11% in the PN
group. The ﬁnal differences in global ERPF between
the groups under analysis are statistically signiﬁcant
(P\0.02), as are the differences between pre- and
postoperative values in the RN group (P\0.02).
Twelve months after surgery, the mean ERPF of the
Table 2 Mean serum creatinine concentration and estimated glomerular ﬁltration rate values with standard deviations (in brackets)
at follow-up points
Creatinine (mmol/l) eGFR (ml/min/1.73 m
2)
RN PN P value
(RN vs. PN)
RN PN P value
(RN vs. PN)
Visit 1 90.5 (19.5) 89.4 (23.3) 0.86 70.8 (18.4) 74.0 (21.1) 0.57
Visit 2 128.1 (25.0) 94.9 (27.3) <0.01 47.1 (9.5) 69.6 (18.4) <0.01
Visit 3 126.4 (24.7) 95.1 (34.9) <0.01 48.1 (10.2) 70.5 (22.8) <0.01
P value (visit 1 vs. visit 2) <0.01 0.08 <0.01 0.10
P value (visit 1 vs. visit 3) <0.01 0.43 <0.01 0.66
Visit 1 preoperative levels, visit 2 postoperative levels 3 months after surgery, visit 3 postoperative levels 12 months after surgery.
GFR glomerular ﬁltration rate, RN radical nephrectomy group, PN partial nephrectomy group
Paired t test and unpaired t test were used to compare creatinine concentration and eGFR at different follow-up points within and
between study groups, respectively
Int Urol Nephrol (2012) 44:745–751 747
123operated kidney in the PN group decreased by 24.7%.
The mean ERPF of the contralateral kidney in the RN
and PN groups grew 3.8 and 0.1%, respectively. The
difference between the ERPF values for the contra-
lateral kidney in the two groups 1 year after surgery is
not statistically signiﬁcant (P[0.02) (Fig. 1).
Age effect on effective renal plasma ﬂow
after renal surgery
Under the hypothesis that the non-operated kidney’s
compensatory hyperfunction is less effective in older
patients, we compared postoperative changes in ERPF
in patients aged B60 and [60 years. Our statistical
analysis has demonstrated that the measured differ-
ences in patients younger and older than 60 are not
signiﬁcant.At the baseline, mean ERPFwas 410.2 and
381.9 ml/min (P[0.02), while 12 months after sur-
gery decreased to 309.7 and 255.0 ml/min (P[0.02),
respectively. Analogous conclusions come when
analyzing these two groups of patients regarding to
the type of operation.
Arterial hypertension effect on effective renal
plasma ﬂow after renal surgery
Finally, we performed an analysis to assess whether
hypertensive patients have less effective renal com-
pensatory mechanisms due to hypertensive nephropa-
thy. Just as with the age effect on ERPF after renal
surgery, the measured differences between normoten-
sive and hypertensive patients are not statistically sig-
niﬁcant. At the baseline mean ERPF in normotensive
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Fig. 1 Global effective renal plasma ﬂow values (ml/min).
Visit 1 preoperative levels, visit 3 postoperative levels
12 months after surgery. RN radical nephrectomy group, PN
partial nephrectomy group
748 Int Urol Nephrol (2012) 44:745–751
123andhypertensivepatients was394.9and389.2 ml/min
(P[0.02), while 12 months after surgery decreased
to 247.0 and 286.8 ml/min (P[0.02), respectively.
Discussion
Our results prompt one to question our current way
of thinking about nephrectomy. The conclusion that
kidney removal deteriorates renal function is not
surprising or insightful. It is apparent, however, that
ourknowledgeonthelong-termeffectofrenalsurgery
is insufﬁcient.
One year after renal surgery, we observed a mean
increase of 27% in serum creatinine concentration.
Simultaneously, we recorded a decrease of 22% in
eGFR and 30% in effective renal plasma ﬂow. All
these changes were more clinically and statistically
signiﬁcant in radically nephrectomized patients than
in partially nephrectomized patients.
First, our results conﬁrm the appropriateness of
nephron-sparing surgery and the need to perform
partial nephrectomy on appropriate patients to avoid
the removal of normal renal parenchyma and conse-
quently excessive deterioration of renal function.
At the 1-year observation point, we recorded a
32% decrease in eGFR in radically nephrectomized
patients, compared to a mere 5% decrease in partially
nephrectomized patients. Similar conclusions stem
from the study published by Clark et al. comparing
creatinine clearance in patients undergoing RN or PN
at the 1-year observation point. The authors demon-
strated a 32% decrease in the RN group and a 6%
decrease in the PN group [5]. The values reported by
Tanaka et al. [6] based on follow-up at 2–4 weeks
were 37 and 5%, respectively. Shirasaki et al. [7]
published a study based on 1-year observation of 30
radically nephrectomized patients reporting a 33%
increaseofserumcreatinineconcentration.Cozzietal.
[8] observed 16 radically and 10 partially nephrec-
tomized children and recorded 36 and 24% growth
in serum creatinine concentration, respectively, 1 year
after surgery.
Second, our study underlines the inefﬁciency of
potential compensatory mechanisms improving renal
functioninthepostoperative period.Thenon-operated
kidney’s compensatory hypertrophy seems not to be
associated with hyperfunction. By deﬁnition, hyper-
trophy entails nephron enlargement, not an increase
in the number of nephrons. However, we intuitively
think that hypertrophy causes hyperfunction. In 1-year
observation, we observed a 4% increase in the non-
operated kidney’s ERPF in radically nephrectomized
patients and a 0.1% increase in partially nephrec-
tomized patients. It is worth remembering that the
operated kidney’s ERPF in partially nephrectomized
patients simultaneously fell by just 25%. Finally, the
deterioration of global renal function measured by the
decrease in global ERPF was three times more
signiﬁcant in radically nephrectomized patients than
in partially nephrectomized patients. Previously pub-
lished studies have focused mainly on the value of
renalscintigraphyinassessingrenalinsufﬁciencyafter
renal surgery. However, they present important data
for discussion of our results. The lack of signiﬁcant
renal compensatory mechanisms is conﬁrmed by the
study published by Groshar et al. [9] reporting no
changes regarding the non-operated kidney’s renal
volume and the percentage injected dose per cubic
centimeter of renal tissue of operated and non-
operated kidneys in 24 patients examined preopera-
tively and 1–6 months after partial nephrectomy.
Ben-Haim et al. [10] reported a 9% increase in the
non-operated kidney’s volume accompanied by a 29%
increase in the percentage injected dose per cubic
centimeter of renal tissue in 30 patients examined
preoperativelyand2–23 monthsafter radical nephrec-
tomy. It is hard to ascertain the underlying cause for
the results of Ben-Haim’s study and our study
differing from one another in this way. The primary
difference rests in the radionucleotide used for renal
scintigraphy and the lack of protocol for follow-up
points in Ben-Haim’s study. Another important aspect
isthat,even thoughtheresultsofhisscintigraphywere
more optimistic than ours, Ben-Haim et al. reported
a surprisingly more signiﬁcant increase in serum
creatinine concentration (49% increase). The authors
concluded that compensatory hyperfunction occurs
soon after surgery, which is totally at odds with our
study’s ﬁndings, and that the postoperative hyper-
function remains intact for at least 1 year, which also
seems to be consistent with our observations.
Our results stand in opposition to some other
studies published in recent years. Anderson et al. [11]
recorded a 33% increase in the non-operated kidney’s
ERPF 1 week after nephrectomy in 55 patients,
Bieniasz et al. [12] reported a 30% decrease in
creatinine clearance in 46 patients 3 months after
Int Urol Nephrol (2012) 44:745–751 749
123nephrectomy, and Goldfarb et al. [13] observed a 28%
decrease in 24-h urinary creatinine clearance in 70
patients 25 years after nephrectomy. All these studies
were based, however, on living kidney donors.
These patients have attributes that are incomparable
with renal cancer patients. Usually, they are healthy
young people with a potentially greater ability for
compensation.
The most important limitations of our study are the
small numberofpatients inthe PNgroup,the lengthof
follow-up, and the reliance on serum creatinine
concentration/eGFR as sole measure of renal function.
During data collection, 18 partial and 33 radical
nephrectomies were performed, illustrating the stage
of renal cancer at the time of diagnosis in Poland.
In the contemporary cohort, 90% of T1a patients
were qualiﬁed for partial nephrectomy.
The study protocol called for three control points
with the last one being 1 year after surgery. Renal
function deterioration proved to be slightly more
advanced 3 months after surgery compared to renal
function deterioration 12 months after surgery.
Although the differences between the postoperative
measurements at 3 and 12 months are not statistically
signiﬁcant, it may be interesting that renal function
signiﬁcantly retarded immediately after surgery
improves in subsequent months. An important ques-
tion that must be posed is whether the compensatory
mechanisms analyzed in our study were insufﬁcient
because of their limited capacity or because of the
observation period was too short. However, even if
compensation becomes effective only after the elapse
of more than a year, we think our conclusions are
correct.
The number of tests assessing renal function is still
rising. However, in the present study, we used only
creatinine serum concentration and eGFR calculated
by MDRD formula. Despite their limitations, these
tests are one of most commonly used in urological
departments ineveryday practice. Whilewe think that
more speciﬁc tests would not change our results
substantially, their use could consolidate our ﬁndings
and increase the scientiﬁc value of the report.
Conclusions
Renal surgery deteriorates global kidney function
proportionately to the volume of renal parenchyma
loss. While a tumor does not produce urine, the
deteriorationofrenalfunctionafterpartialnephrectomy
is nearly insigniﬁcant clinically. At 1-year observation,
potential compensatory mechanisms are totally insufﬁ-
cient and global renal function does not improve. The
hypothesis regarding hyperfunction of contralateral
kidney should be revised because hyperfunction is not
clinically or statistically signiﬁcant. Having regard for
the study’s methodological limits, further investigation
is needed to conﬁrm the results and conclusions
deﬁnitively.
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